Contact
Scientific Posters

Fully Human VHH CAR Platforms Driving Next-Generation Cell Therapeutics

Nona Biosciences has developed fully human heavy-chain-only antibody (HCAb) platforms to advance CAR-T therapy design. This poster highlights:

    • Validation of HCAD-based BCMA-CAR leads with strong cytotoxicity and survival benefits
    • Use of lipid nanoparticles (LNPs) to efficiently deliver HCAb-based CAR constructs
    • Evidence that fully human VHH CARs streamline development and improve therapeutic potential

Download the full poster to explore data on in vivo validation, optimized delivery, and how this approach opens new avenues for next-generation CAR therapies.

Download our Scientific Poster!

Contact Our Team

Click Here
Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Youtube
Consent to display content from - Youtube
Vimeo
Consent to display content from - Vimeo
Google Maps
Consent to display content from - Google
Spotify
Consent to display content from - Spotify
Sound Cloud
Consent to display content from - Sound
Contact